Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

NLM Logo

4,5-Dihydro-1-(3-(trifluoromethyl)phenyl)-1H-pyrazol-3-amine MeSH Descriptor Data 2026


MeSH Heading
4,5-Dihydro-1-(3-(trifluoromethyl)phenyl)-1H-pyrazol-3-amine
Tree Number(s)
D03.383.129.539.180
Unique ID
D015772
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/D015772
Scope Note
A dual inhibitor of both cyclooxygenase and lipoxygenase pathways. It exerts an anti-inflammatory effect by inhibiting the formation of prostaglandins and leukotrienes. The drug also enhances pulmonary hypoxic vasoconstriction and has a protective effect after myocardial ischemia.
Entry Term(s)
BW-755C
BW755C
Pharm Action
Anti-Inflammatory Agents, Non-Steroidal
Lipoxygenase Inhibitors
Cyclooxygenase Inhibitors
Registry Numbers
66000-40-6
0
CAS Type 1 Name
1H-Pyrazol-3-amine, 4,5-dihydro-1-(3-(trifluoromethyl)phenyl)-
Previous Indexing
Anti-Inflammatory Agents (1966-1986)
Anti-Inflammatory Agents, Non-Steroidal (1987-1989)
Pyrazoles (1966-1989)
Public MeSH Note
2005; see BW-775C 1996-2004; see BW 755C 1990; see BW-755C 1990-1995
History Note
2005(1991)
Date Introduced
1990/01/01
Last Updated
2018/06/30
4,5-Dihydro-1-(3-(trifluoromethyl)phenyl)-1H-pyrazol-3-amine Preferred
BW-755C Narrower
page delivered in 0.148s